Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Syncope
Clinical narrative: I have had a consistently elevated resting HR (over 100bpm, always tachycardia) since getting the vaccine and experienced upwards of 50 Palpitations a day shortly after receiving the second dose.; 50 Palpitations a day shortly after receiving the second dose.; heart racing and shortness of breath remain unchanged.; heart racing and shortness of breath remain unchanged.; I am experiencing peripheral neuropathy in my left arm and feet on an almost daily basis which I have never had before.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old male patient received BNT162b2 (BNT162B2), on 27May2021 as dose 2, single (Lot number: EW0187) at the age of 30 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "No" (unspecified if ongoing), notes: known allergies: No, other medical history : No. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EW017D, Location of injection: Arm Left), administration date: 22Apr2021, when the patient was 30-year-old, for Covid-19 immunization. The following information was reported: PALPITATIONS (disability) with onset 31May2021 at 12:00, outcome "not recovered", described as "50 Palpitations a day shortly after receiving the second dose."; NEUROPATHY PERIPHERAL (disability) with onset 31May2021 at 12:00, outcome "not recovered", described as "I am experiencing peripheral neuropathy in my left arm and feet on an almost daily basis which I have never had before."; TACHYCARDIA (disability) with onset 31May2021 at 12:00, outcome "not recovered", described as "I have had a consistently elevated resting HR (over 100bpm, always tachycardia) since getting the vaccine and experienced upwards of 50 Palpitations a day shortly after receiving the second dose."; PALPITATIONS (disability), DYSPNOEA (disability) all with onset 31May2021 at 12:00, outcome "not recovered" and all described as "heart racing and shortness of breath remain unchanged.". The events "i have had a consistently elevated resting hr (over 100bpm, always tachycardia) since getting the vaccine and experienced upwards of 50 palpitations a day shortly after receiving the second dose.", "50 palpitations a day shortly after receiving the second dose.", "heart racing and shortness of breath remain unchanged." and "i am experiencing peripheral neuropathy in my left arm and feet on an almost daily basis which i have never had before." required physician office visit. The patient underwent the following laboratory tests and procedures: Echocardiogram: (unspecified date) Unknown results; Electrocardiogram: (unspecified date) Unknown results; Heart rate: (unspecified date) over 100bpm, notes: Halter Monitor; (unspecified date) 60-70bpm, notes: Halter Monitor; SARS-CoV-2 test: (01Dec2021) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of tachycardia, palpitations, palpitations, dyspnoea, neuropathy peripheral. Clinical course: The patient have had a consistently elevated resting HR (over 100bpm, always tachycardia) since getting the vaccine and experienced upwards of 50 Palpitations a day shortly after receiving the second dose. The palpitations have slowed to maybe 5 a day, but are still bad and his heart racing and shortness of breath remain unchanged. He was now unable to exercise because of the amount of palpitations get. In addition, he was experiencing peripheral neuropathy in his left arm and feet on an almost daily basis which have never had before. For reference, his resting HR used to be around 60-70bpm. Treatments included EKG, Holter Monitor, Cardiac Echo (inconclusive). Patient had no covid prior vaccination. Tested post vaccination and result included covid test post vaccination : [{covid test type post vaccination=Nasal swab, covid test name post vaccination=Abbot BinaNOW Antigen Self Test , covid test result=Negative}]. No known allergies.  Follow-up attempts are completed. No further information is expected.